And down the line the discovery of that myostatin protein gene, could play a role ... have recently been testing myostatin inhibitors in phase three trials in patients with spinal muscular atrophy ...

Roche’s decision comes after Pfizer said it was ending work on its antibody-based myostatin inhibitor domagrozumab ... evidence that while inhibiting the protein could boost muscle mass it ...

Studies suggest that by acting as a decoy receptor for myostatin—a protein believed to inhibit muscular tissue development—ACE-031 may offer novel avenues for research into wasting disorders that ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...

when the protein is inhibited, there is more muscle growth and weight loss. Based on the trial results, Scholar Rock, is now seeking FDA approval for their myostatin inhibitor, which is based on a ...